Literature DB >> 15120725

Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli.

Sophie Payot1, Laetitia Avrain, Catherine Magras, Karine Praud, Axel Cloeckaert, Elisabeth Chaslus-Dancla.   

Abstract

Thirty-eight avian and swine French isolates of Campylobacter coli were studied for their mechanisms of co-resistance to fluoroquinolones and erythromycin. A Thr86Ile modification of GyrA, responsible for fluoroquinolone resistance, was found in all the strains. Two different levels of resistance to erythromycin (MIC of 8-16 or >/=256 mg/l) were observed. A A2075G mutation in the 23S rRNA genes was found only in the highly-resistant strains. Phe-Arg-beta-naphthylamide, an efflux pump inhibitor, potentiated erythromycin in all the strains examined but restored susceptibility only in the strains with a low-level of resistance. This suggests the involvement of efflux in intrinsic and in acquired low-level of resistance to erythromycin in C. coli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120725     DOI: 10.1016/j.ijantimicag.2003.12.008

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  25 in total

1.  Assessing sensitivity to antibacterial topoisomerase II inhibitors.

Authors:  Sonia K Morgan-Linnell; Hiroshi Hiasa; Lynn Zechiedrich; John L Nitiss
Journal:  Curr Protoc Pharmacol       Date:  2007-12

Review 2.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 3.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

4.  Campylobacter coli in swine production: antimicrobial resistance mechanisms and molecular epidemiology.

Authors:  Siddhartha Thakur; Wondwossen A Gebreyes
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

5.  Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Mirva Lehtopolku; Pirkko Kotilainen; Marjo Haanperä-Heikkinen; Ulla-Maija Nakari; Marja-Liisa Hänninen; Pentti Huovinen; Anja Siitonen; Erkki Eerola; Jari Jalava; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

6.  Salicylate functions as an efflux pump inducer and promotes the emergence of fluoroquinolone-resistant Campylobacter jejuni mutants.

Authors:  Zhangqi Shen; Xiao-Ying Pu; Qijing Zhang
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

7.  Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens.

Authors:  Jun Lin; Meiguan Yan; Orhan Sahin; Sonia Pereira; Yun-Juan Chang; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

8.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.

Authors:  Amera Gibreel; Veronica N Kos; Monika Keelan; Cathy A Trieber; Simon Levesque; Sophie Michaud; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Natural transformation-mediated transfer of erythromycin resistance in Campylobacter coli strains from turkeys and swine.

Authors:  Joo-Sung Kim; Donna K Carver; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

Review 10.  Antibiotic resistance in Campylobacter: emergence, transmission and persistence.

Authors:  Taradon Luangtongkum; Byeonghwa Jeon; Jing Han; Paul Plummer; Catherine M Logue; Qijing Zhang
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.